EE128 Cost-Effectiveness of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Vs. Entecavir for Chronic Hepatitis B Patients in Greece
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.431
https://www.valueinhealthjournal.com/article/S1098-3015(23)00531-4/fulltext
Title :
EE128 Cost-Effectiveness of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Vs. Entecavir for Chronic Hepatitis B Patients in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00531-4&doi=10.1016/j.jval.2023.03.431
First page :
Section Title :
Open access? :
No
Section Order :
11816